Thomas Adams

Insider Reports History

Entity
Individual
Signature
/s/ Thomas Adams
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Adams:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cardiff Oncology, Inc. Former Director Stock Options 478K $1.24M $2.60 Jun 10, 2021 Direct
Hepion Pharmaceuticals, Inc. Director Stock Options 291K May 18, 2021 Direct

Insider Reports Filed by Thomas Adams

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRDF Cardiff Oncology, Inc. Jun 10, 2021 7 $0 4 Jun 14, 2021 Former Director
HEPA Hepion Pharmaceuticals, Inc. May 18, 2021 1 $0 4 May 20, 2021 Director